Brown Advisory
LAB icon

Brown Advisory’s Standard BioTools LAB Stock Holding History

Brown Advisory’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,944
Closed -$212K – 1156
2019
Q1 		$212K Buy
15,944
+2,657
+20% +$28K ﹤0.01% 1229
2018
Q4 		$115K Buy
+13,287
New +$104K ﹤0.01% 1207

Other funds holding LAB

EIP
Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brown Advisory's LAB Position: Q2 2019 in Review

Brown Advisory sold out of Standard BioTools (LAB) in Q2 2019, closing a stake of 15,944 shares — an estimated $212K sold.

Brown Advisory first reported a position in LAB in Q4 2018 and held it in 2 quarters. The position peaked at $212K in Q1 2019. 135 funds tracked by Wall St. Rank hold LAB as of Q2 2019.

  • Brown Advisory reported no remaining Standard BioTools position as of Q2 2019 after selling out during the quarter.
  • Brown Advisory sold 15,944 Standard BioTools shares in Q2 2019, an estimated $212K.
  • Brown Advisory first reported a position in Standard BioTools in Q4 2018 and held it in 2 quarters.
  • Brown Advisory's Standard BioTools position peaked at $212K in Q1 2019.
  • 135 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2019.

Based on Brown Advisory's 13F filing for Q2 2019, filed 12 Aug 2019.